ICU Medical (ICUI) Stock Price

ICU Medical Price

NASDAQ·CLOSED
166.37USD-0.59 (-0.35 %)
Market closed

Over the last 19 years ICU Medical grew revenue by 13.5% annually, reaching 2.23 B USD. Earnings per share have declined at 19.3% per year over the last 19 years. For ICU Medical, the net margin of 0.0% is down versus 7.8% a few years ago. The consensus 12-month price target for ICU Medical is 183.60 USD, about 10.4% above where the stock trades today. Of 12 analysts, 10 rate the stock a buy — an overall Buy consensus. The stock trades about 55% above its 52-week low.

ICU Medical stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of ICU Medical over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how ICU Medical stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing ICU Medical's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

ICU Medical Stock Price History
DateICU Medical Price
8/6/2026166.37 USD
8/5/2026166.96 USD
8/4/2026171.15 USD
8/3/2026172.94 USD
7/31/2026168.51 USD
7/30/2026168.38 USD
7/29/2026165.80 USD
7/27/2026160.55 USD
7/23/2026153.46 USD
7/22/2026157.44 USD
7/21/2026158.77 USD
7/20/2026157.34 USD
7/17/2026157.51 USD
7/16/2026162.17 USD
7/15/2026157.96 USD
7/14/2026153.49 USD
7/13/2026155.85 USD
7/10/2026154.42 USD
7/9/2026156.52 USD
7/8/2026152.63 USD
7/7/2026155.37 USD
7/6/2026155.04 USD
7/2/2026154.97 USD
7/1/2026148.46 USD
6/30/2026146.60 USD
6/29/2026146.68 USD
6/26/2026148.27 USD
6/25/2026148.83 USD
6/24/2026142.95 USD
6/23/2026135.52 USD
6/22/2026137.55 USD
6/18/2026139.99 USD
6/17/2026140.82 USD
6/16/2026141.91 USD
6/15/2026144.14 USD
6/12/2026143.40 USD
6/11/2026138.91 USD
6/10/2026142.65 USD
6/9/2026142.00 USD
6/8/2026137.48 USD
6/5/2026137.80 USD
6/4/2026138.05 USD
6/3/2026130.13 USD
6/2/2026132.46 USD
6/1/2026132.88 USD
5/29/2026137.57 USD
5/28/2026139.54 USD
5/27/2026140.17 USD
5/26/2026134.38 USD
5/22/2026130.81 USD
5/21/2026126.99 USD
5/20/2026125.77 USD
5/19/2026123.66 USD
5/18/2026123.08 USD
5/15/2026118.72 USD
5/14/2026122.99 USD
5/13/2026122.04 USD
5/12/2026123.23 USD
5/11/2026124.68 USD
5/8/2026126.43 USD
5/7/2026123.07 USD
5/6/2026119.59 USD
5/5/2026117.01 USD
5/4/2026118.67 USD
5/1/2026118.85 USD
4/30/2026119.20 USD
4/29/2026115.45 USD
4/28/2026121.01 USD
4/27/2026122.85 USD
4/24/2026124.82 USD
4/23/2026124.55 USD
4/22/2026127.36 USD
4/21/2026128.15 USD
4/20/2026130.58 USD
4/17/2026129.96 USD
4/16/2026126.04 USD
4/15/2026126.21 USD
4/14/2026127.85 USD
4/13/2026129.32 USD
4/10/2026125.68 USD
4/9/2026125.83 USD
4/8/2026123.92 USD
4/7/2026119.83 USD
4/6/2026122.99 USD
4/2/2026123.31 USD
4/1/2026125.22 USD
3/31/2026129.15 USD
3/30/2026125.38 USD
3/27/2026124.19 USD
3/26/2026127.65 USD
3/25/2026131.38 USD
3/24/2026129.40 USD
3/23/2026129.93 USD
3/20/2026125.36 USD
3/19/2026126.63 USD
3/18/2026126.63 USD
3/17/2026130.55 USD
3/16/2026126.96 USD
3/13/2026125.85 USD
3/12/2026128.78 USD
3/11/2026133.76 USD
3/10/2026132.41 USD
3/9/2026133.34 USD
3/6/2026132.00 USD
3/5/2026136.74 USD
3/4/2026142.46 USD
3/3/2026142.66 USD
3/2/2026146.99 USD
2/27/2026150.58 USD
2/26/2026150.82 USD
2/25/2026155.12 USD
2/24/2026152.47 USD
2/23/2026151.57 USD
2/20/2026157.03 USD
2/19/2026149.74 USD
2/18/2026151.63 USD
2/17/2026148.29 USD
2/13/2026144.90 USD
2/12/2026142.02 USD
2/11/2026147.73 USD
2/10/2026153.22 USD
2/9/2026151.86 USD
2/6/2026154.16 USD
2/5/2026149.64 USD
2/4/2026149.98 USD
2/3/2026150.69 USD
2/2/2026151.45 USD
1/30/2026149.90 USD
1/29/2026150.03 USD
1/28/2026149.28 USD
1/27/2026149.27 USD
1/26/2026152.86 USD
1/23/2026152.67 USD
1/22/2026158.54 USD
1/21/2026155.13 USD
1/20/2026153.23 USD
1/16/2026156.17 USD
1/15/2026155.12 USD
1/14/2026148.52 USD
1/13/2026148.28 USD
1/12/2026151.19 USD
1/9/2026152.99 USD
1/8/2026151.65 USD
1/7/2026150.32 USD
1/6/2026150.78 USD
1/5/2026144.12 USD
1/2/2026138.53 USD
12/31/2025142.67 USD
12/30/2025144.63 USD
12/29/2025147.23 USD
12/26/2025147.87 USD
12/24/2025146.98 USD
12/23/2025147.50 USD
12/22/2025148.33 USD
12/19/2025145.15 USD
12/18/2025146.17 USD
12/17/2025146.37 USD
12/16/2025147.07 USD
12/15/2025148.03 USD
12/12/2025148.43 USD
12/11/2025147.22 USD
12/10/2025147.59 USD
12/9/2025142.48 USD
12/8/2025143.77 USD
12/5/2025142.51 USD
12/4/2025142.35 USD
12/3/2025144.04 USD
12/2/2025146.66 USD
12/1/2025146.22 USD
11/28/2025148.44 USD
11/26/2025149.14 USD
11/25/2025151.90 USD
11/24/2025148.54 USD
11/21/2025142.34 USD
11/20/2025134.33 USD
11/19/2025132.57 USD
11/18/2025134.03 USD
11/17/2025134.52 USD
11/14/2025136.50 USD
11/13/2025138.53 USD
11/12/2025139.15 USD
11/11/2025143.22 USD
11/10/2025139.23 USD
11/7/2025140.16 USD
11/6/2025129.67 USD
11/5/2025127.38 USD
11/4/2025125.66 USD
11/3/2025122.86 USD
10/31/2025120.09 USD
10/30/2025119.74 USD
10/29/2025117.67 USD
10/28/2025120.11 USD
10/27/2025122.91 USD
10/24/2025123.59 USD
10/23/2025121.67 USD
10/22/2025122.35 USD
10/21/2025121.00 USD
10/20/2025117.34 USD
10/17/2025118.47 USD
10/16/2025116.49 USD
10/15/2025116.29 USD
10/14/2025117.31 USD
10/13/2025116.26 USD
10/10/2025112.92 USD
10/9/2025116.89 USD
10/8/2025120.31 USD
10/7/2025118.10 USD
10/6/2025121.38 USD
10/3/2025122.11 USD
10/2/2025120.91 USD
10/1/2025121.69 USD
9/30/2025119.96 USD
9/29/2025117.04 USD
9/28/2025117.04 USD
9/25/2025118.81 USD
9/24/2025118.26 USD
9/23/2025129.90 USD
9/22/2025131.87 USD
9/19/2025131.13 USD
9/18/2025133.02 USD
9/17/2025129.10 USD
9/16/2025130.36 USD
9/15/2025132.17 USD
9/12/2025130.39 USD
9/11/2025135.03 USD
9/10/2025133.57 USD
9/9/2025130.57 USD
9/8/2025130.58 USD
9/5/2025129.01 USD
9/4/2025125.63 USD
9/3/2025124.10 USD
9/2/2025127.02 USD
8/29/2025127.02 USD
8/28/2025127.04 USD
8/27/2025127.42 USD
8/26/2025125.94 USD
8/25/2025125.81 USD
8/22/2025128.19 USD
8/21/2025121.75 USD
8/20/2025123.36 USD
8/19/2025123.76 USD
8/18/2025122.96 USD
8/15/2025120.95 USD
8/14/2025111.90 USD
8/13/2025114.13 USD
8/12/2025110.32 USD
8/11/2025108.10 USD
8/8/2025112.85 USD
Access this data via the Eulerpool API
Get Free API Key

ICU Medical Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
2.26 B USD
22.83 M USD
-29.66 M USD
Jan 1, 2024
2.38 B USD
42.96 M USD
-117.69 M USD
Jan 1, 2025
2.23 B USD
108.55 M USD
732,000.00 USD
Jan 1, 2026 (e)
2.17 B USD
65.92 M USD
199.13 M USD
Jan 1, 2027 (e)
2.27 B USD
68.78 M USD
226.96 M USD
Jan 1, 2028 (e)
2.36 B USD
71.58 M USD
247.54 M USD
Jan 1, 2029 (e)
2.31 B USD
70.06 M USD
256.07 M USD
Jan 1, 2030 (e)
2.36 B USD
71.72 M USD
270.46 M USD

ICU Medical Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 8, 2026, 2:56 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
0.340.381.291.401.271.271.322.282.262.382.232.172.272.362.312.36
10.3611.14240.908.36-9.570.393.5473.25-0.925.44-6.38-2.604.334.10-2.122.34
52.7953.0332.9740.7137.2036.2737.3130.5732.7134.5936.7336.7336.7336.7336.7336.73
180.00201.00426.00570.00471.00461.00491.00697.00739.00824.00819.00797.70832.22866.38848.01867.85
68.0082.0053.0030.00107.0098.00123.00-42.0022.0042.00108.0065.0068.0071.0070.0071.00
19.9421.644.102.148.457.719.35-1.840.971.764.842.993.003.013.033.00
44.0063.0068.0028.00101.0086.00103.00-74.00-29.00-117.00–199.00226.00247.00256.00270.00
69.2343.187.94-58.82260.71-14.8519.77-171.84-60.81303.45––13.579.293.645.47
16.7017.5621.3420.4921.3921.6121.8123.9924.1424.4924.6924.6924.6924.6924.6924.69
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales ICU Medical generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue ICU Medical retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare ICU Medical's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares ICU Medical has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against ICU Medical's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

ICU Medical stock margins

The ICU Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of ICU Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for ICU Medical.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
37.34 %
9.36 %
7.84 %
Jan 1, 2022
30.60 %
-1.88 %
-3.26 %
Jan 1, 2023
32.75 %
1.01 %
-1.31 %
Jan 1, 2024
34.62 %
1.80 %
-4.94 %
Jan 1, 2025
36.76 %
4.87 %
0.03 %
Jan 1, 2026 (e)
36.76 %
3.03 %
9.17 %
Jan 1, 2027 (e)
36.76 %
3.03 %
10.01 %
Jan 1, 2028 (e)
36.76 %
3.03 %
10.49 %

ICU Medical Stock Revenue, EBIT, Earnings per Share

The ICU Medical earnings per share therefore indicates how much revenue ICU Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
60.36 USD
5.65 USD
4.73 USD
Jan 1, 2022
95.05 USD
-1.79 USD
-3.10 USD
Jan 1, 2023
93.58 USD
0.95 USD
-1.23 USD
Jan 1, 2024
97.26 USD
1.75 USD
-4.81 USD
Jan 1, 2025
90.33 USD
4.40 USD
0.03 USD
Jan 1, 2026 (e)
89.09 USD
2.67 USD
8.17 USD
Jan 1, 2027 (e)
92.95 USD
2.79 USD
9.31 USD
Jan 1, 2028 (e)
96.73 USD
2.90 USD
10.15 USD

ICU Medical business model & stock analysis

ICU Medical Inc is a US medical technology company specializing in the development and production of innovative products for infusion and oncology therapy. It was founded in 1984 by Dr. George A. Lopez and has become a leading manufacturer of disposable products for infusion therapy. The company offers a wide range of disposable products for infusion and oncology therapy, including solutions, medication administration systems, catheters, syringes, tubes, and sensors. They also manufacture medical devices such as syringe pumps, medication administration pumps, and gravity infusion devices. ICU Medical Inc collaborates with other companies in the medical and pharmaceutical industries to provide comprehensive solutions for intravenous therapy. The company's product range includes syringes, tubes, catheters, combination products, infusion and syringe pumps, and the Clave technology for closed infusion pump systems.

ICU Medical SWOT Analysis

Strengths

ICU Medical Inc has a strong market presence and brand reputation in the medical device industry.

The company offers a wide range of innovative and high-quality medical products, meeting the diverse needs of healthcare providers.

ICU Medical Inc has a robust distribution network, enabling efficient delivery of its products worldwide.

Weaknesses

ICU Medical Inc relies heavily on a limited number of key suppliers, which could result in potential supply chain disruptions.

The company may face challenges in keeping up with rapidly evolving healthcare regulations and compliance requirements.

ICU Medical Inc has high research and development costs, which can impact its profitability.

Opportunities

The increasing global demand for healthcare services presents an opportunity for ICU Medical Inc to expand its market share.

Advancements in medical technology open doors for the development and introduction of new and improved medical devices.

ICU Medical Inc can explore strategic partnerships or acquisitions to enhance its product portfolio and market reach.

Threats

Intense competition in the medical device industry puts pressure on pricing and reduces profit margins for ICU Medical Inc.

Changes in healthcare policies and reimbursement systems can impact the demand and adoption of medical devices.

Economic downturns and fluctuations in exchange rates can affect the company's financial performance in international markets.

ICU Medical Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

ICU Medical Employees
Details
Date
ICU Medical Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

ICU Medical Segments

ICU Medical Revenue by Segment (1/2)

  • 3 Years

  • 5 Years

  • Max

Infusion Consumables
Infusion Systems
Vital Care
IV Solutions
Infusion Consumables-Smiths Medical
Vascular Access
Critical Care
Other Revenue
Details
Date
Infusion Consumables
Infusion Systems
Vital Care
IV Solutions
Infusion Consumables-Smiths Medical
Vascular Access
Critical Care
Other Revenue
Jan 1, 2018
483.04 M USD
355.48 M USD
0.00 USD
507.99 M USD
0.00 USD
0.00 USD
53.53 M USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
473.74 M USD
359.69 M USD
0.00 USD
388.97 M USD
0.00 USD
0.00 USD
48.60 M USD
0.00 USD
Jan 1, 2021
555.19 M USD
352.32 M USD
0.00 USD
359.48 M USD
0.00 USD
0.00 USD
49.32 M USD
0.00 USD
Jan 1, 2022
566.62 M USD
351.08 M USD
284.61 M USD
363.47 M USD
340.12 M USD
326.77 M USD
47.33 M USD
0.00 USD
Jan 1, 2023
969.13 M USD
629.04 M USD
660.95 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
1.04 B USD
652.41 M USD
690.77 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
1.11 B USD
684.21 M USD
437.92 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

ICU Medical Revenue by Segment (2/2)

  • 3 Years

  • 5 Years

  • Max

Infusion Consumables
Infusion Systems
IV Solutions
Critical Care
Other Revenue
Details
Date
Infusion Consumables
Infusion Systems
IV Solutions
Critical Care
Other Revenue
Jan 1, 2018
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
477.61 M USD
328.28 M USD
414.97 M USD
45.34 M USD
0.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2022
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

ICU Medical Revenue by Region

  • 3 Years

  • 5 Years

  • Max

United States
EMEA
Foreign
APAC [Domain]
Other foreign countries
Europe
CANADA
Other LATAM
Asia Pacific
Details
Date
United States
EMEA
Foreign
APAC [Domain]
Other foreign countries
Europe
CANADA
Other LATAM
Asia Pacific
Jan 1, 2018
1.05 B USD
134.36 M USD
345.36 M USD
0.00 USD
211.00 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
923.34 M USD
130.53 M USD
342.87 M USD
0.00 USD
212.34 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
910.63 M USD
132.76 M USD
360.38 M USD
0.00 USD
227.61 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
941.81 M USD
147.49 M USD
374.50 M USD
0.00 USD
227.01 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2022
1.46 B USD
367.41 M USD
0.00 USD
257.21 M USD
195.31 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
1.44 B USD
373.57 M USD
0.00 USD
241.70 M USD
203.84 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
1.53 B USD
393.53 M USD
0.00 USD
232.82 M USD
223.59 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
1.36 B USD
411.68 M USD
0.00 USD
232.90 M USD
230.56 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

ICU Medical Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

ICU Medical historical P/E ratio, EBIT multiple, and P/S ratio

ICU Medical annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

ICU Medical shares outstanding

The number of shares of ICU Medical was 24.69 M in 2025. This indicates how many shares ICU Medical is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
21.81 M Stocks
Jan 1, 2022
23.99 M Stocks
Jan 1, 2023
24.14 M Stocks
Jan 1, 2024
24.49 M Stocks
Jan 1, 2025
24.69 M Stocks
Jan 1, 2026 (e)
24.69 M Stocks
Jan 1, 2027 (e)
24.69 M Stocks
Jan 1, 2028 (e)
24.69 M Stocks

ICU Medical stock splits

In ICU Medical's history, there have been no stock splits.

Current ICU Medical forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
83.33 % (10)
Hold
16.67 % (2)
Sell
0.00 % (0)
12M Price Target
183.60
Last Price
166.37
Currency
USD
12M Return Potential
10.36 %
LTM Return
0 %

ICU Medical Analyst Rating Actions

DateFirmActionRatingReliability
7/21/2026
Keybanc
Keybanc
MaintainedOverweight49
5/27/2026
Needham
Needham
UpgradeHoldBuy70
4/27/2026
Keybanc
Keybanc
MaintainedOverweight49
4/17/2026
Piper Sandler
Piper Sandler
MaintainedOverweight51
2/20/2026
Piper Sandler
Piper Sandler
MaintainedOverweight51
2/20/2026
Keybanc
Keybanc
MaintainedOverweight49
11/7/2025
Piper Sandler
Piper Sandler
MaintainedOverweight51
11/7/2025
Keybanc
Keybanc
MaintainedOverweight49
10/21/2025
Keybanc
Keybanc
MaintainedOverweight49
9/10/2025
Piper Sandler
Piper Sandler
MaintainedOverweight51

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

ICU Medical Earnings Calls

2025

ICU Medical Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/10/20261.94USD-544.10 MUSD-2026 Q2
5/11/20261.79USD-530.89 MUSD-2026 Q1
2/19/20261.73USD-541.25 MUSD-2025 Q4
11/12/20241.28USD-586.19 MUSD-2024 Q3
5/6/20240.92USD-566.92 MUSD-2024 Q1
2/26/20241.24USD-574.11 MUSD-2023 Q4
8/7/20231.62USD-591.95 MUSD-2023 Q2
5/8/20231.32USD-565.96 MUSD-2023 Q1
2/22/20231.59USD-588.60 MUSD-2022 Q4
11/7/20221.49USD-573.48 MUSD-2022 Q3
...

EESG©

Eulerpool ESG Scorecard© for the ICU Medical stock

44/100
23
Environment
65
Social
46
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

ICU Medical shareholder structure

% Name
14.79548%
BLACKROCK, INC.
BLACKROCK, INC.
10.97266%
JANUS HENDERSON GROUP PLC
JANUS HENDERSON GROUP PLC
5.89501%
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC
5.00467%
FULLER & THALER ASSET MANAGEMENT, INC.
FULLER & THALER ASSET MANAGEMENT, INC.
4.55911%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
4.03396%
DIMENSIONAL FUND ADVISORS LP
DIMENSIONAL FUND ADVISORS LP
...

ICU Medical Beneficial Ownership Filings (SEC 13D/G)

Free Float
98.0%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
100.00%
Clifford Teller
Clifford Teller
SEC ↗
13.00%
Abigail P. Johnson
Abigail P. Johnson
SEC ↗
12.97%
135521910
135521910
SEC ↗
12.97%
061523639
061523639
SEC ↗
11.00%
13-1957714
13-1957714
SEC ↗
11.00%
only)
only)
SEC ↗
11.00%
Zurich Scudder Investments, Inc.
Zurich Scudder Investments, Inc.
SEC ↗
11.00%
Scudder Kemper Investments, Inc.
Scudder Kemper Investments, Inc.
SEC ↗
11.00%
Scudder, Stevens & Clark, Inc.
Scudder, Stevens & Clark, Inc.
SEC ↗
10.80%
EIN #00-0000000
EIN #00-0000000
SEC ↗

ICU Medical Executives and Management Board

12 members · avg. age 58 · 33 % women

VJ

Mr. Vivek Jain (53)

Chairman of the Board, Chief Executive Officer · since 2014

6.45 M USD

Management

CV

Mr. Christian Voigtlander (57)

Chief Operating Officer

4.04 M USD
BB

Mr. Brian Bonnell (51)

Chief Financial Officer, Treasurer

3.99 M USD
VS

Ms. Virginia Sanzone (50)

Corporate Vice President, General Counsel, Secretary

2.90 M USD
DW

Mr. Daniel Woolson (48)

President

2.07 M USD
JM

Mr. John Mills

Investor Relations · since 2022

–

Board of Directors

DG

Mr. David Greenberg (58)

Lead Independent Director

296,019.00 USD
DH

Mr. David Hoffmeister (70)

Independent Director

282,019.00 USD
EF

Ms. Elisha Finney (63)

Independent Director

265,019.00 USD
DA

Mr. Donald Abbey (58)

Independent Director

255,019.00 USD
LH

Ms. Laurie Hernandez (67)

Independent Director

255,019.00 USD
KK

Ms. Kolleen Kennedy (65)

Independent Director

255,019.00 USD

ICU Medical Supply Chain

ICU Medical Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
8 companies
#Nameβ 1YTrend
1
Pfizer
Supplier·Customer·Pharmaceuticals·US
-0.04
0.81
0.02
0.12
0.20
0.57
0.11
#Nameβ 1YTrend
1
Analytica
Supplier·Customer·Health Care Equipment & Supplies·AU
0.21
0.51
0.58
0.44
-0.28
—
—
2
Vocera Communications, Inc.
Supplier·Customer·Health Care Technology·US
0.09
-0.86
-0.66
-0.54
-0.08
—
—
3
Model N
Supplier·Software·US
-0.54
0.74
0.59
0.60
0.10
-0.30
—
4
Covetrus Inc
Customer·Health Care Providers & Services·US
0.64
-0.54
0.04
0.29
-0.36
-0.26
—
5
GVS
Customer·Machinery·IT
0.81
0.58
0.48
0.36
-0.14
-0.12
-0.16

Frequently asked questions about ICU Medical

ICU Medical Inc is a healthcare company that specializes in the development, manufacture, and sale of medical devices, consumables, and services. Its business model revolves around providing innovative and cost-effective solutions to improve patient care and safety. ICU Medical Inc focuses on critical care, oncology, and infusion therapy markets, offering products like infusion pumps, needle-free connectors, and custom infusion sets. By collaborating with healthcare professionals and maintaining a customer-centric approach, the company aims to enhance patient outcomes and streamline healthcare delivery. ICU Medical Inc's commitment to innovation, quality, and customer satisfaction drives its business strategy and growth in the healthcare industry.

ICU Medical Inc is primarily active in the healthcare industry.

The main competitors of ICU Medical Inc in the market include Becton, Dickinson and Company, Fresenius Kabi AG, and Baxter International Inc.

ICU Medical Inc. is a renowned company in the healthcare industry. Established in 1984, ICU Medical has a rich history of delivering innovative medical devices and solutions. The company provides a wide range of products, including infusion therapy, critical care, and oncology systems, designed to enhance patient safety and improve medical outcomes. ICU Medical has grown significantly over the years and has become a global leader in infusion therapy technology. With a commitment to quality and continuous innovation, ICU Medical continues to play a vital role in revolutionizing the healthcare sector and improving patient care worldwide.

ICU Medical Inc., a leading global provider of medical devices, has achieved several significant milestones over the years. One notable achievement is the acquisition of Hospira Infusion Systems from Pfizer in 2017. This strategic acquisition expanded ICU Medical's product portfolio and strengthened its position in the infusion therapy market. Additionally, ICU Medical Inc. received FDA clearance for its innovative Clave™ Needlefree Connector, which has revolutionized intravenous therapy by reducing the risk of infections. Furthermore, the company has consistently demonstrated strong financial performance, marked by revenue growth and profitability. With a commitment to innovation and quality, ICU Medical Inc. continues to make strides in improving patient care and addressing critical healthcare challenges.

ICU Medical Inc is primarily present in the United States, with its headquarters located in San Clemente, California. In addition to its strong presence in the domestic market, ICU Medical Inc operates in various other countries and regions across the globe. The company has offices and facilities in Europe, including Germany, France, and the United Kingdom, as well as in the Asia-Pacific region, with locations in Australia, China, and Japan. With a global reach, ICU Medical Inc is able to serve healthcare institutions and providers worldwide, offering innovative medical technologies and solutions.

ICU Medical Inc represents the values of innovation, quality, and patient safety. With a commitment to advancing healthcare, the company focuses on developing and delivering innovative medical devices and solutions. ICU Medical Inc's corporate philosophy emphasizes collaboration, integrity, and a patient-centric approach. By consistently meeting the highest standards of excellence, the company strives to improve patient outcomes and enhance the overall healthcare experience. With a strong emphasis on research and development, ICU Medical Inc is dedicated to providing healthcare professionals with cutting-edge technologies that support optimal patient care.

Analysts currently set an average price target of 185.03 USD for the ICU Medical stock (median: 183.60 USD), implying +11.2 % versus the latest price. The consensus is based on 12 analyst ratings.

ICU Medical Analyst Price Targets 2026

12 analysts currently rate the ICU Medical stock: 10 recommend buying, 2 holding and 0 selling. For 2026, analysts expect ICU Medical to generate revenue of 2.17 B USD and earnings per share of 8.07 USD.

ICU Medical Analyst Price Targets 2026

Converted at the current exchange rate, the ICU Medical share trades at 144.02 EUR (166.37 USD).

The ICU Medical share (ICUI) is listed on 5 stock exchanges, including: NASDAQ (ICUI), Frankfurt (IC7.F), München (IC7.MU), Düsseldorf (IC7.DU), SIX (Zürich) (IC7.SW).

ICU Medical Inc is a globally operating company specializing in the development and manufacturing of innovative medical products. The company serves various sectors such as infusion therapy, oncology, and intensive care medicine. With its extensive portfolio of products, ICU Medical Inc aims to contribute to improving patient care worldwide.

The expected revenue of ICU Medical is 2.17 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of ICU Medical is 199.13 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of ICU Medical is currently 20.63. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the ICU Medical stock.

The price-to-sales ratio (P/S) of ICU Medical is currently 1.89. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the ICU Medical stock.

The Eulerpool Quality Score for ICU Medical is 3/10.

The ISIN of ICU Medical is US44930G1076. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of ICU Medical is 894139. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of ICU Medical is ICUI. The ticker symbol is used to trade ICU Medical shares on the stock exchange.

ICU Medical paid dividends every year for the past 0 years.

ICU Medical is assigned to the 'Health' sector.

The dividends of ICU Medical are distributed in USD.

All fundamentals and in-depth analysis of ICU Medical

Our stock analysis for ICU Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ICU Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

ICU Medical Stock
ICU Medical Revenue→
ICU Medical Stock
ICU Medical Net Income→
ICU Medical Stock
ICU Medical P/E→
ICU Medical Stock
ICU Medical P/S→
ICU Medical Stock
ICU Medical EBIT→
ICU Medical Stock
ICU Medical Dividend→
ICU Medical Stock
ICU Medical Directors Dealings→
ICU Medical Stock
ICU Medical Stocks→
ICU Medical Stock
ICU Medical Market capitalization→
ICU Medical Stock
ICU Medical Debt→
ICU Medical Stock
ICU Medical Liabilities→
ICU Medical Stock
ICU Medical Equity→
ICU Medical Stock
ICU Medical AAQS→
ICU Medical Stock
ICU Medical Employees→
ICU Medical Stock
ICU Medical ROE→
ICU Medical Stock
ICU Medical ROA→
ICU Medical Stock
ICU Medical ROCE→
ICU Medical Stock
ICU Medical News→
ICU Medical Stock
ICU Medical Analyst Price Targets→

Health Stocks

IDEAYA BiosciencesIconovoIDEXX LaboratoriesIconic LabsIDL Diagnostics AB (publ)ICONIdorsiaIcecure MedicalIDT AustraliaIcares MedicusIfa SystemsIbnsina Pharma Co SAEAll Stocks A–Z →